UMH Properties UMH climbs 142 percent even after posting a large Q4 2025 earnings miss relative to analyst estimates Amgen Inc AMGN Stem Cell Therapy Leadership Meets Balanced NearTerm Valuation Dynamics ICCC ImmuCell Corporation shares climb 444 percent after its fourth quarter 2025 earnings release BBUC Brookfld Biz CEO outlines crosssector investment plans to boost longterm organic growth momentum LENZ Therapeutics LENZ Stock Market Influencing Factors LENZ Therapeutics posts 171 EPS miss on wider quarterly loss